ReviewTherapeutic advances in hematology2022

Chimeric antigen receptor (CAR) T-cell treatment for mantle cell lymphoma (MCL).

Bushra Tbakhi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.